Peptide record

TPDB06195

Antibacterial Anticancer standard
11 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06195
Antibacterial Anticancer
Anti-infective peptides Cancer-related peptides
AntiBP3 Peptipedia
standard
No
A 11-aa standard-residue multi-activity (Antibacterial and Anticancer) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
ILILILILKRK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C66H126N16O12
ANDCEQGHMFPSTWYV
IL
1335.83
11.64
3
0
8
+3
-1.21
1.900
283.64
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
0
0.00
0
Residue Composition
number
0
A
1
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
4
I
4
L
2
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 4 L: 4 K: 2 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
11 reviewed residue count
C66H126N16O12 sequence-only estimate (linear, free termini)
1335.83 sequence-only estimate (linear, free termini)
11.64 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-1.21 sequence-only estimate (linear, free termini)
1.900 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA